{"product_id":"evaluating-an-acquisition-from-the-target-firms-viewpoint-von-ziga-bobinac","title":"Evaluating an Acquisition from the Target Firm's Viewpoint","description":"\u003cp\u003eEvaluating acquisitions is a delicate matter because it is difficult to assume what would have happened in the absence of a deal. This book tries to assess Novartis¿ acquisition in terms of the impact on the Slovenian generic pharmaceutical company Lek. Facing several problems with how to measure the effects of M\u0026amp;A on the acquired firm, success can be assessed from two main aspects: a.) The degree to which previously set goals have been reached; and b.) The performance of the acquired firm in comparison to its peers in key areas of the sector. With insights from 4 C-level members of Lek and Krka, this book offers a unique understanding of reasons for taking very different paths of two leading Slovenian companies in the last 20 years.\u003c\/p\u003e\u003cdiv class=\"aw-variant-hidden-subtitle-div\" id=\"aw-variant-subtitle-9783330008557\"\u003e\u003ch3\u003e\u003c\/h3\u003e\u003c\/div\u003e","brand":"Libri","offers":[{"title":"Softcover - 9783330008557","offer_id":39421856383069,"sku":"9783330008557","price":49.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/0622\/files\/122924b4-126c-4ce3-bf99-d9ee9395fe6f.jpg?v=1774674870","url":"https:\/\/shop.autorenwelt.de\/en\/products\/evaluating-an-acquisition-from-the-target-firms-viewpoint-von-ziga-bobinac","provider":"Autorenwelt Shop","version":"1.0","type":"link"}